Market Research Logo

Sorrento Therapeutics, Inc. - Product Pipeline Review - 2016

Sorrento Therapeutics, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Sorrento Therapeutics, Inc. - Product Pipeline Review - 2016’, provides an overview of the Sorrento Therapeutics, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Sorrento Therapeutics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Sorrento Therapeutics, Inc.
  • The report provides overview of Sorrento Therapeutics, Inc. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Sorrento Therapeutics, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Sorrento Therapeutics, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Sorrento Therapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Sorrento Therapeutics, Inc.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Sorrento Therapeutics, Inc.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Sorrento Therapeutics, Inc. Snapshot
Sorrento Therapeutics, Inc. Overview
Key Information
Key Facts
Sorrento Therapeutics, Inc. - Research and Development Overview
Key Therapeutic Areas
Sorrento Therapeutics, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Sorrento Therapeutics, Inc. - Pipeline Products Glance
Sorrento Therapeutics, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Sorrento Therapeutics, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Sorrento Therapeutics, Inc. - Drug Profiles
Cellular Immunotherapy to Target CEA for Oncology
Product Description
Mechanism of Action
R&D Progress
Cellular Immunotherapy to Target PD-L1 for Oncology
Product Description
Mechanism of Action
R&D Progress
Cellular Immunotherapy to Target PSMA for Prostate Cancer
Product Description
Mechanism of Action
R&D Progress
BA-0702
Product Description
Mechanism of Action
R&D Progress
CBA-0710
Product Description
Mechanism of Action
R&D Progress
Cellular Immunotherapy to Target c-KIT for Solid Tumors
Product Description
Mechanism of Action
R&D Progress
Cellular Immunotherapy to Target CD123 for Acute Myeloid Leukemia
Product Description
Mechanism of Action
R&D Progress
Cellular Immunotherapy to Target CD33 for Acute Myeloid Leukemia
Product Description
Mechanism of Action
R&D Progress
Cellular Immunotherapy to Target GD3 for Solid Tumors
Product Description
Mechanism of Action
R&D Progress
Cellular Immunotherapy to Target HER-2 for Glioblastoma
Product Description
Mechanism of Action
R&D Progress
Cellular Immunotherapy to Target HER2 for Oncology
Product Description
Mechanism of Action
R&D Progress
Cellular Immunotherapy to Target IL13R Alpha2 for Glioblastoma Multiforme
Product Description
Mechanism of Action
R&D Progress
Cellular Immunotherapy to Target MUC-16 for Ovarian Cancer
Product Description
Mechanism of Action
R&D Progress
Cellular Immunotherapy to Target ROR1 for Solid Tumor
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody to Inhibit CD47 for Oncology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody to Inhibit Ghrelin for Obesity
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody to Target EGFR and Inhibit PD-L1 for Oncology
Product Description
Mechanism of Action
R&D Progress
rituximab biosimilar
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit c-Myc for Solid Tumors and Hematological Malignancies
Product Description
Mechanism of Action
R&D Progress
STI-600
Product Description
Mechanism of Action
R&D Progress
STIA-0168
Product Description
Mechanism of Action
R&D Progress
STIA-1011
Product Description
Mechanism of Action
R&D Progress
STIA-1012
Product Description
Mechanism of Action
R&D Progress
STIA-1014
Product Description
Mechanism of Action
R&D Progress
STIA-1015
Product Description
Mechanism of Action
R&D Progress
STIA-1110
Product Description
Mechanism of Action
R&D Progress
STIB-0201
Product Description
Mechanism of Action
R&D Progress
STIC-0205
Product Description
Mechanism of Action
R&D Progress
STID-0602
Product Description
Mechanism of Action
R&D Progress
BC-001
Product Description
Mechanism of Action
R&D Progress
clostridium difficile vaccine
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibodies for Clostridium difficile
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibodies for Hepatitis C
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibodies to Inhibit WISP1 for Idiopathic Pulmonary Fibrosis
Product Description
Mechanism of Action
R&D Progress
STI-001
Product Description
Mechanism of Action
R&D Progress
Sorrento Therapeutics, Inc. - Pipeline Analysis
Sorrento Therapeutics, Inc. - Pipeline Products by Target
Sorrento Therapeutics, Inc. - Pipeline Products by Route of Administration
Sorrento Therapeutics, Inc. - Pipeline Products by Molecule Type
Sorrento Therapeutics, Inc. - Pipeline Products by Mechanism of Action
Sorrento Therapeutics, Inc. - Recent Pipeline Updates
Sorrento Therapeutics, Inc. - Dormant Projects
Sorrento Therapeutics, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
paclitaxel
Sorrento Therapeutics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Sorrento Therapeutics, Inc., Key Information
Sorrento Therapeutics, Inc., Key Facts
Sorrento Therapeutics, Inc. - Pipeline by Indication, 2016
Sorrento Therapeutics, Inc. - Pipeline by Stage of Development, 2016
Sorrento Therapeutics, Inc. - Monotherapy Products in Pipeline, 2016
Sorrento Therapeutics, Inc. - Partnered Products in Pipeline, 2016
Sorrento Therapeutics, Inc. - Partnered Products/ Combination Treatment Modalities, 2016
Sorrento Therapeutics, Inc. - Phase II, 2016
Sorrento Therapeutics, Inc. - Phase I, 2016
Sorrento Therapeutics, Inc. - Preclinical, 2016
Sorrento Therapeutics, Inc. - Discovery, 2016
Sorrento Therapeutics, Inc. - Pipeline by Target, 2016
Sorrento Therapeutics, Inc. - Pipeline by Route of Administration, 2016
Sorrento Therapeutics, Inc. - Pipeline by Molecule Type, 2016
Sorrento Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2016
Sorrento Therapeutics, Inc. - Recent Pipeline Updates, 2016
Sorrento Therapeutics, Inc. - Dormant Developmental Projects,2016
Sorrento Therapeutics, Inc. - Discontinued Pipeline Products, 2016
Sorrento Therapeutics, Inc., Subsidiaries
List of Figures
Sorrento Therapeutics, Inc. - Pipeline by Top 10 Indication, 2016
Sorrento Therapeutics, Inc. - Pipeline by Stage of Development, 2016
Sorrento Therapeutics, Inc. - Monotherapy Products in Pipeline, 2016
Sorrento Therapeutics, Inc. - Partnered Products in Pipeline, 2016
Sorrento Therapeutics, Inc. - Pipeline by Top 10 Target, 2016
Sorrento Therapeutics, Inc. - Pipeline by Top 10 Molecule Type, 2016
Sorrento Therapeutics, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report